Toxicological Implications of Polymorphic Drug Metabolism

作者: J.C. Ritchie , T.P. Sloan , J.R. Idle , R.L. Smith

DOI: 10.1002/9780470720592.CH12

关键词:

摘要: The occurrence of genetic polymorphisms drug metabolism means that populations contain subgroups (phenotypes) differ sharply in their abilities to effect a number metabolic reactions. Because this, major interphenotype differences occur responsiveness drugs and toxic substances. well established acetylation hydrolysis illustrate the important association exists between phenotype propensity develop exaggerated responses some Recently, for oxidation, new polymorphism has been described it promises provide better understanding inter-individual variability handling of, to, following effects are here: (a) its influence determining variable presystemic hence systemic availability; (b) role alternative pathways individuals who have genetically determined impairment oxidative capacity (c) on development agranulocytosis associated with metiamide administration.

参考文章(45)
J. Kapitulnik, P. J. Poppers, A. H. Conney, Comparative metabolism of benzo[a]pyrene and drugs in human liver Clinical Pharmacology & Therapeutics. ,vol. 21, pp. 166- 176 ,(1977) , 10.1002/CPT1977212166
W.G. Manderson, Q fever; report of a case. The Lancet. ,vol. 2, pp. 1085- 1086 ,(1949) , 10.1016/S0140-6736(49)91653-0
John J. Mieyal, S. V. Lucas, U. A. Siddiqui, L. T. Webster, J. M. Strong, Identification of separate acyl- CoA:glycine and acyl-CoA:L-glutamine N-acyltransferase activities in mitochondrial fractions from liver of rhesus monkey and man. Journal of Biological Chemistry. ,vol. 251, pp. 3352- 3358 ,(1976) , 10.1016/S0021-9258(17)33444-0
George D. Sweeney, Ken Jones, George Lee, Emmanuel Farber, Ross Cameron, A relative deficiency of cytochrome P-450 and aryl hydrocarbon [benzo(a)pyrene] hydroxylase in hyperplastic nodules induced by 2-acetylaminofluorene in rat liver. Cancer Research. ,vol. 36, pp. 3888- 3893 ,(1976)
R W Brimblecombe, W A M Duncan, G J Durant, J C Emmett, C R Ganellin, M E Parsons, Cimetidine—A Non-Thiourea H2-Receptor Antagonist Journal of International Medical Research. ,vol. 3, pp. 86- 92 ,(1975) , 10.1177/030006057500300205
J Caldwell, J O'Gorman, RL Smith, Inter-individual differences in the glycine conjugation of salicylic acid [proceedings]. British Journal of Clinical Pharmacology. ,vol. 9, ,(1980) , 10.1111/J.1365-2125.1980.TB04816.X
R.M. Welch, A.H. Conney, J.J. Burns, The metabolism of acetophenetidin and N-acetyl-p-aminophenol in the cat Biochemical Pharmacology. ,vol. 15, pp. 521- 531 ,(1966) , 10.1016/0006-2952(66)90018-9
Edward J. Feldman, Jon I. Isenberg, Effects of Metiamide on Gastric Acid Hypersecretion, Steatorrhea and Bone-Marrow Function in a Patient with Systemic Mastocytosis New England Journal of Medicine. ,vol. 295, pp. 1178- 1179 ,(1976) , 10.1056/NEJM197611182952108
E. Pantuck, K. Hsiao, A. Conney, W. Garland, A Kappas, K. Anderson, A. Alvares, Effect of charcoal-broiled beef on phenacetin metabolism in man Science. ,vol. 194, pp. 1055- 1057 ,(1976) , 10.1126/SCIENCE.982059
Terrence F. Blaschke, Peter C. Rubin, Hepatic first-pass metabolism in liver disease. Clinical Pharmacokinectics. ,vol. 4, pp. 423- 432 ,(1979) , 10.2165/00003088-197904060-00002